Cargando…

LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis

Accumulating evidence reveals the principal role of long noncoding RNAs in the progression of clear cell renal cell carcinoma (ccRCC). However, little is known about the underlying mechanism of ADAM metallopeptidase with thrombospondin type 1 motif, 9 antisense RNA 2 (ADAMTS9-AS2) in ccRCC. Here, bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Er-lin, Xing, Li, Wang, Liang, Song, Wen-ting, Li, Dan-bin, Wang, Yi, Gu, Yi-wei, Liu, Ming-ming, Ni, Wen-jun, Zhang, Peng, Ma, Xin, Zhang, Xu, Yao, Jie, Chen, Yang, An, Rui-hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710069/ https://www.ncbi.nlm.nih.gov/pubmed/31400752 http://dx.doi.org/10.18632/aging.102154

Ejemplares similares

lncRNA ADAMTS9-AS2 Controls Human Mesenchymal Stem Cell Chondrogenic Differentiation and Functions as a ceRNA
por: Huang, Ming-Jian, et al.
Publicado: (2019)

lncRNA-GM targets Foxo1 to promote T cell–mediated autoimmunity
por: Chen, Yali, et al.
Publicado: (2022)

LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis
por: Ren, Niansheng, et al.
Publicado: (2020)

Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis
por: Zhu, Zi-Jiang, et al.
Publicado: (2021)

LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis
por: Zhao, Jianjun, et al.
Publicado: (2023)

Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis
por: Xue, Sheng, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
por: Lin, Zhichao, et al.
Publicado: (2021)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis
por: Zhang, Ming-xiao, et al.
Publicado: (2021)

IGF2BP2 Induces U251 Glioblastoma Cell Chemoresistance by Inhibiting FOXO1-Mediated PID1 Expression Through Stabilizing lncRNA DANCR
por: Han, Junfei, et al.
Publicado: (2022)

An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma
por: Tang, Cheng, et al.
Publicado: (2021)

LncRNA H19 promotes the differentiation of bovine skeletal muscle satellite cells by suppressing Sirt1/FoxO1
por: Xu, Xiaochun, et al.
Publicado: (2017)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network
por: Gong, Ke, et al.
Publicado: (2021)

LncRNA ADAMTS9‐AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating SPOP
por: Wang, Feiran, et al.
Publicado: (2020)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022)

LncRNA MBNL1‐AS1 represses cell proliferation and enhances cell apoptosis via targeting miR‐135a‐5p/PHLPP2/FOXO1 axis in bladder cancer
por: Wei, Xiaosong, et al.
Publicado: (2019)

FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling
por: Ling, Jing, et al.
Publicado: (2019)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma
por: Xu, Ben, et al.
Publicado: (2015)

LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis
por: Guo, Wen, et al.
Publicado: (2019)

Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer
por: Wan, Jiahui, et al.
Publicado: (2020)

A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma
por: Zhai, Wei, et al.
Publicado: (2019)

LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells
por: La, Ting, et al.
Publicado: (2023)

Identification of cancer hallmark‐associated gene and lncRNA cooperative regulation pairs and dictate lncRNA roles in oral squamous cell carcinoma
por: Lin, Ken, et al.
Publicado: (2020)

LncRNA ADAMTS9-AS1 knockdown suppresses cell proliferation and migration in glioma through downregulating Wnt/β-catenin signaling pathway
por: Zhou, Chunhui, et al.
Publicado: (2022)

A Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma
por: Zhang, Lulu, et al.
Publicado: (2023)

A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
por: Dou, Qian, et al.
Publicado: (2021)

Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2023)

Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model
por: Qu, GenYi, et al.
Publicado: (2023)

Identification of a lncRNA-associated competing endogenous RNA-regulated network in clear cell renal cell carcinoma
por: Liu, Beibei, et al.
Publicado: (2019)

RBM47 restrains renal cell carcinoma progression and chemoresistance through interacting with lncRNA HOXB-AS1
por: Su, Qingfu, et al.
Publicado: (2023)

KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis
por: Zhu, Yaru, et al.
Publicado: (2021)

LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma
por: Wang, Yanliang, et al.
Publicado: (2022)

Role of H3K27 methylation in the regulation of lncRNA expression
por: Wu, Susan C., et al.
Publicado: (2010)

Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma
por: Wang, Gang, et al.
Publicado: (2022)

Corrigendum: Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer
por: Wan, Jiahui, et al.
Publicado: (2020)

A novel coagulation-related lncRNA predicts the prognosis and immune of clear cell renal cell carcinoma
por: Wu, Wensong, et al.
Publicado: (2023)

Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
por: Zhu, Liyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ol31lspgjacss7k76rlc9nfi0n